New heart pump trial offers hope for shock patients
Disease control
Recruiting now
This study is testing a new temporary heart pump (Magenta Elevate) in 10 people with cardiogenic shock, a life-threatening condition where the heart can't pump enough blood. The pump is inserted through a blood vessel to help the left ventricle work. The goal is to see if it's sa…
Phase: NA • Sponsor: Magenta Medical Ltd. • Aim: Disease control
Last updated May 10, 2026 23:45 UTC